Correlation Between BioLine RX and Foresight Autonomous
Can any of the company-specific risk be diversified away by investing in both BioLine RX and Foresight Autonomous at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLine RX and Foresight Autonomous into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLine RX and Foresight Autonomous Holdings, you can compare the effects of market volatilities on BioLine RX and Foresight Autonomous and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLine RX with a short position of Foresight Autonomous. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLine RX and Foresight Autonomous.
Diversification Opportunities for BioLine RX and Foresight Autonomous
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between BioLine and Foresight is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding BioLine RX and Foresight Autonomous Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foresight Autonomous and BioLine RX is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLine RX are associated (or correlated) with Foresight Autonomous. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foresight Autonomous has no effect on the direction of BioLine RX i.e., BioLine RX and Foresight Autonomous go up and down completely randomly.
Pair Corralation between BioLine RX and Foresight Autonomous
Assuming the 90 days trading horizon BioLine RX is expected to generate 1.38 times more return on investment than Foresight Autonomous. However, BioLine RX is 1.38 times more volatile than Foresight Autonomous Holdings. It trades about -0.08 of its potential returns per unit of risk. Foresight Autonomous Holdings is currently generating about -0.12 per unit of risk. If you would invest 3,410 in BioLine RX on September 12, 2024 and sell it today you would lose (2,700) from holding BioLine RX or give up 79.18% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
BioLine RX vs. Foresight Autonomous Holdings
Performance |
Timeline |
BioLine RX |
Foresight Autonomous |
BioLine RX and Foresight Autonomous Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioLine RX and Foresight Autonomous
The main advantage of trading using opposite BioLine RX and Foresight Autonomous positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLine RX position performs unexpectedly, Foresight Autonomous can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foresight Autonomous will offset losses from the drop in Foresight Autonomous' long position.BioLine RX vs. Evogene | BioLine RX vs. Enlivex Therapeutics | BioLine RX vs. Kamada | BioLine RX vs. Compugen |
Foresight Autonomous vs. Raval ACS | Foresight Autonomous vs. Tadir Gan 1993 | Foresight Autonomous vs. Mivne Real Estate | Foresight Autonomous vs. Photomyne |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |